| 18-Nov-25 |
Buy |
Jeremy Millard |
2.37p | 168,776 |
£3,999.99 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.37p | 50,000 |
£1,182.50 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.30p | 100,000 |
£2,300.00 |
| 05-Feb-25 |
Buy |
Carolyn Rand |
3.59p | 100 |
£3.59 |
| 18-Nov-25 |
Buy |
Jeremy Millard |
2.37p | 168,776 |
£3,999.99 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.30p | 100,000 |
£2,300.00 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.37p | 50,000 |
£1,182.50 |
| 05-Feb-25 |
Buy |
Carolyn Rand |
3.59p | 100 |
£3.59 |
| Jeremy Millard |
1,193,776 |
£22,284 |
| Carolyn Rand |
347,500 |
£6,487 |
| Spreadex Ltd |
22,432,673 |
£418,743 |
| Spreadex Ltd |
19,086,256 |
£356,277 |
| Spreadex Ltd |
17,761,256 |
£331,544 |
| Cantor Fitzgerald Europe |
14,516,000 |
£270,965 |
| Mobeus Equity Partners LLP |
8,333,250 |
£155,554 |
| Unicorn Asset Management |
4,266,650 |
£79,644 |
| 08:18 |
1,000 @ 1.92p |
| 08:18 |
8,736 @ 1.92p |
| 08:12 |
661 @ 1.97p |
| 08:00 |
19,552 @ 1.92p |
Top of Page
You are here:
research